Home » Topics » BioWorld Science

BioWorld Science
RSS

Vertex Pharmaceuticals identifies new APOL1 inhibitors

Jan. 5, 2022

Novartis presents new Cav1.2 activators

Jan. 5, 2022

Incyte divulges new ACVR1 inhibitors

Jan. 5, 2022

MCUF-651, a GC-A PAM for the treatment of cardiovascular, renal and metabolic diseases

Jan. 5, 2022

Amgen discloses new SCN9A blockers

Jan. 5, 2022

Activation of ATF4 is required for DLBCL growth

Jan. 5, 2022

OR5B21 is associated with breast cancer metastasis

Jan. 5, 2022

Garvan Institute awarded grant to investigate new treatment approach for pancreatic cancer

Jan. 4, 2022

Kyverna licenses CAR T construct for use in autologous and allogeneic therapies

Jan. 4, 2022

Ascletis announces new oral direct-acting antivirals being developed for SARS-CoV-2 infection

Jan. 4, 2022

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...